Get the Stockscreener App
2.13
25.78%
-0.74
After Hours:
2.12
-0.010
-0.47%
Cibus Inc stock is traded at $2.13, with a volume of 2.65M.
It is down -25.78% in the last 24 hours and down -39.49% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$2.87
Open:
$2.3
24h Volume:
2.65M
Relative Volume:
5.50
Market Cap:
$147.39M
Revenue:
$3.64M
Net Income/Loss:
$-132.20M
P/E Ratio:
-0.7146
EPS:
-2.9806
Net Cash Flow:
$-51.17M
1W Performance:
-19.92%
1M Performance:
-39.49%
6M Performance:
+63.85%
1Y Performance:
+7.58%
1-Day Range:
$1.96
$2.30
1-Week Range:
$1.96
$2.88
52-Week Range:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.13 | 198.59M | 3.64M | -132.20M | -51.17M | -2.9806 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each - Stock Titan
Cibus stock dips after pricing $15M offering - MSN
Cibus announces underwritten public offering of Class A shares By Investing.com - Investing.com Australia
Cibus prices $15 million public offering at $2.15 per share By Investing.com - Investing.com India
Cibus sells nearly 7M shares to fund rice weed-trait development - Stock Titan
Cibus announces public offering of Class A common stock and pre-funded warrants - MSN
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 earnings call transcript - MSN
Cibus announces Class A common stock offering, no amount given - TipRanks
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Cibus (NASDAQ: CBUS) seeks capital via Class A shares and pre-funded warrants - Stock Titan
Cibus, Inc. Announces Proposed Public Offering Of Class A Common Stock And Pre-Funded Warrants - TradingView
Cibus seeks new capital for rice weed-trait work through stock sale - Stock Titan
Cibus (CBUS) Sees Analyst Laurence Alexander Raise Price Target - GuruFocus
Cibus (NASDAQ:CBUS) Price Target Raised to $3.00 at Jefferies Financial Group - MarketBeat
Cibus price target raised to $3 from $1.90 at Jefferies - TipRanks
Stock Report: Is Cibus Inc stock risky to hold nowPortfolio Risk Report & Pattern Based Trade Signal System - baoquankhu1.vn
Sidoti Brokers Increase Earnings Estimates for Cibus - MarketBeat
CBUS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cibus Reports Q4 2025 Results, Advances Rice Program Toward 2027 Commercial Launch - iGrow News
Cibus, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cibus, Inc. Earnings Call Signals Promise Amid Pressure - TipRanks
Cibus Q4 Earnings Call Highlights - MarketBeat
Cibus (CBUS) Q4 2025 Earnings Call Transcript - AOL.com
Cibus Inc: Sr VP Sauer sells $5 in stock By Investing.com - Investing.com India
Cibus Inc: Sr VP Sauer sells $5 in stock - Investing.com
Cibus (CBUS) CFO logs small 1,496-share tax-withholding disposition - Stock Titan
Cibus (CBUS) SVP reports minor share sale and tax withholding - Stock Titan
Cibus (NASDAQ: CBUS) CLO reports 13,109-share tax-withholding dispositions - Stock Titan
Cibus Inc. Accelerates Crop Productivity with Proprietary Gene Editing Technologies and Rapid Trait Development System (RTDS) - Minichart
Cibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
Cibus targets $200M annual rice royalties with expanded Latin America and India push while advancing biofragrance commercialization - MSN
Cibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus reports Q4 EPS (59c) vs. (87c) last year - TipRanks
Cibus, Inc. Q4 2025 Earnings Call Highlights - Intellectia AI
Cibus (CBUS) Sets Sights on Global Expansion with Promising Rice Program - GuruFocus
Cibus (CBUS) Reports Lower Q4 Revenue Amid Strategic Developments - GuruFocus
Cibus: 2025 Landmark Year in Gene Editing Commercialization & EU Regulatory ShiftNews and Statistics - IndexBox
Cibus (CBUS) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
Earnings call transcript: Cibus Q4 2025 shows cost cuts, stock up By Investing.com - Investing.com India
CIBUS ($CBUS) Releases Q4 2025 Earnings - Quiver Quantitative
Earnings call transcript: Cibus Q4 2025 shows cost cuts, stock up - Investing.com Australia
Cibus Inc’s 2025 Earnings Call: EU Gene Editing Timelines and Biofragrance Revenue Roadmaps Clash - Bitget
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Cibus 2025 Financial Results: Quarterly and Annual Revenue & LossNews and Statistics - IndexBox
Cibus (NASDAQ:CBUS) Releases Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat
Cibus: Q4 Earnings Snapshot - marketscreener.com
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus 2025 10-K: Revenue $3.6M, EPS loss $2.78 - TradingView
Cibus (NASDAQ: CBUS) doubles down on gene-edited rice traits amid funding risk - Stock Titan
Cibus Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):